These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 10850436

  • 21. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R, Wang Y, D'Agostini F, Izzotti A, Lubet RA, You M, De Flora S.
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [Abstract] [Full Text] [Related]

  • 22. Inconsistency between workplace and spousal studies of environmental tobacco smoke and lung cancer.
    LeVois ME, Layard MW.
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):309-16. PubMed ID: 8090954
    [Abstract] [Full Text] [Related]

  • 23. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT.
    Cancer Res; 2001 Jan 15; 61(2):612-5. PubMed ID: 11212258
    [Abstract] [Full Text] [Related]

  • 24. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P.
    Lung Cancer; 2007 Jan 15; 55(1):25-34. PubMed ID: 17059853
    [Abstract] [Full Text] [Related]

  • 25. Genotoxicity of environmental tobacco smoke: a review.
    Husgafvel-Pursiainen K.
    Mutat Res; 2004 Nov 15; 567(2-3):427-45. PubMed ID: 15572289
    [Abstract] [Full Text] [Related]

  • 26. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2000 Oct 15; 9(10):1037-42. PubMed ID: 11045785
    [Abstract] [Full Text] [Related]

  • 27. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure.
    Wang X, Christiani DC, Wiencke JK, Fischbein M, Xu X, Cheng TJ, Mark E, Wain JC, Kelsey KT.
    Cancer Epidemiol Biomarkers Prev; 1995 Oct 15; 4(5):543-8. PubMed ID: 7549812
    [Abstract] [Full Text] [Related]

  • 28. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA.
    Cancer Res; 2003 Aug 15; 63(16):4842-8. PubMed ID: 12941804
    [Abstract] [Full Text] [Related]

  • 29. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
    Bennett WP, von Brevern MC, Zhu SM, Bartsch H, Muehlbauer KR, Hollstein MC.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 15; 6(11):963-6. PubMed ID: 9367071
    [Abstract] [Full Text] [Related]

  • 30. Environmental tobacco smoke and lung cancer in nonsmokers: does time since exposure play a role?
    Nyberg F, Agrenius V, Svartengren K, Svensson C, Pershagen G.
    Epidemiology; 1998 May 15; 9(3):301-8. PubMed ID: 9583423
    [Abstract] [Full Text] [Related]

  • 31. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer.
    Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M.
    Cancer Res; 1996 Jan 01; 56(1):72-6. PubMed ID: 8548778
    [Abstract] [Full Text] [Related]

  • 32. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
    Kawaguchi T, Ando M, Kubo A, Takada M, Atagi S, Okishio K, Asami K, Matsumura A, Tsujino K, Ignatius OS, Sasaki H.
    Clin Cancer Res; 2011 Jan 01; 17(1):39-45. PubMed ID: 21059816
    [Abstract] [Full Text] [Related]

  • 33. The TP53 gene, tobacco exposure, and lung cancer.
    Toyooka S, Tsuda T, Gazdar AF.
    Hum Mutat; 2003 Mar 01; 21(3):229-39. PubMed ID: 12619108
    [Abstract] [Full Text] [Related]

  • 34. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
    Kannio A, Ridanpää M, Koskinen H, Partanen T, Anttila S, Collan Y, Hietanen E, Vainio H, Husgafvel-Pursiainen K.
    Cancer Epidemiol Biomarkers Prev; 1996 Jan 01; 5(1):33-9. PubMed ID: 8770464
    [Abstract] [Full Text] [Related]

  • 35. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P, Srivatanakul P, Randerson-Moor J, Vipasrinimit S, Lalitwongsa S, Unpunyo P, Bashir S, Bishop DT.
    Cancer Epidemiol Biomarkers Prev; 2006 Apr 01; 15(4):667-74. PubMed ID: 16614107
    [Abstract] [Full Text] [Related]

  • 36. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
    Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Husgafvel-Pursiainen K, Schoket B.
    Mutagenesis; 2009 Nov 01; 24(6):475-80. PubMed ID: 19643813
    [Abstract] [Full Text] [Related]

  • 37. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S, Balansky RM, D'Agostini F, Izzotti A, Camoirano A, Bennicelli C, Zhang Z, Wang Y, Lubet RA, You M.
    Cancer Res; 2003 Feb 15; 63(4):793-800. PubMed ID: 12591728
    [Abstract] [Full Text] [Related]

  • 38. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
    Gao WM, Romkes M, Siegfried JM, Luketich JD, Keohavong P.
    Mol Carcinog; 2006 Nov 15; 45(11):828-32. PubMed ID: 16865671
    [Abstract] [Full Text] [Related]

  • 39. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.
    Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K.
    Mutagenesis; 2012 Jul 15; 27(4):423-9. PubMed ID: 22217548
    [Abstract] [Full Text] [Related]

  • 40. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
    Jeon HS, Kim KM, Park SH, Lee SY, Choi JE, Lee GY, Kam S, Park RW, Kim IS, Kim CH, Jung TH, Park JY.
    Carcinogenesis; 2003 Oct 15; 24(10):1677-81. PubMed ID: 12869423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.